Joo-Hyuk Son Selected Research

Joo-Hyuk Son Research Topics

15	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2017
7	Ovarian Epithelial Carcinoma 03/2024 - 07/2018
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 01/2016
4	Carcinoma (Carcinomatosis) 01/2024 - 08/2022
4	Neoplasms (Cancer) 03/2023 - 01/2016
3	Endometrial Neoplasms (Endometrial Cancer) 01/2024 - 09/2021
2	Margins of Excision 01/2023 - 09/2020
1	Residual Neoplasm 10/2023
1	Ascites 09/2023
1	Cholecystitis 03/2023
1	Fistula 06/2022
1	Encephalitis (Encephalitis, Rasmussen) 10/2021
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 10/2021
1	Teratoma (Teratoid Tumor) 10/2021
1	Ovarian Teratoma 10/2021
1	Lymphedema (Milroy Disease) 09/2021
1	Hemorrhage 06/2019
1	Anastomotic Leak 06/2019
1	Sepsis (Septicemia) 10/2018
1	Anemia 10/2018
1	Fever (Fevers) 10/2018
1	Septic Shock (Toxic Shock Syndrome) 10/2018
1	Thrombocytopenia (Thrombopenia) 10/2018

4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 01/2023
3	PlatinumIBA 12/2023 - 08/2022
2	Bevacizumab (Avastin)FDA Link 12/2023 - 06/2022
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2024
1	Immunoconjugates (Immunoconjugate)IBA 01/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2024
1	Progestins (Progestagens)IBA 01/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2021
1	Indicators and Reagents (Reagents)IBA 10/2018
1	squamous cell carcinoma-related antigenIBA 01/2016

10	Cytoreduction Surgical Procedures 12/2023 - 01/2017
6	Therapeutics 01/2024 - 10/2016
4	Neoadjuvant Therapy 11/2023 - 07/2018
3	Lymph Node Excision (Lymph Node Dissection) 03/2024 - 09/2020
3	Drug Therapy (Chemotherapy) 12/2023 - 09/2021
3	Colpotomy 01/2023 - 09/2020
3	Hysterectomy 09/2020 - 01/2016
2	Immunotherapy 01/2024 - 10/2021
2	Cholecystectomy 03/2023 - 03/2021
2	Colectomy 06/2019 - 01/2019
1	Hyperthermic Intraperitoneal Chemotherapy 11/2023
1	Minimally Invasive Surgical Procedures 01/2023
1	Radiotherapy 06/2022
1	Operative Time 06/2019
1	Adjuvant Chemotherapy 10/2018
1	Splenectomy 10/2018